{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Nitrofurantoin",
        "BD Phoenix\u2122 Automated Microbiology System for use with Nitrofurantoin 4 - 128 \u03bcg/mL - Gram-positive ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K082852",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K060324",
        "K020323",
        "K020322",
        "K031589"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "January 5, 2009",
    "Summary Letter Received Date": "January 6, 2009",
    "Submission Date": "December 15, 2008",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Nitrofurantoin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-negative aerobic and facultative anaerobic bacteria",
        "Pure culture isolates of Gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument",
        "BD Phoenix panels"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated susceptibility testing",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System with Nitrofurantoin addition for rapid AST of Gram-positive and Gram-negative bacteria",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration of most Gram-negative aerobic and facultative anaerobic bacteria and most Gram-positive bacteria isolates (Staphylococcus, Enterococcus, Streptococcus) from pure culture using Nitrofurantoin in Gram-positive ID/AST or AST only BD Phoenix panels",
    "fda_folder": "Microbiology"
}